Holen Sie sich die Stockscreener-App
3.07
7.81%
-0.26
Handel nachbörslich:
3.26
0.19
+6.19%
Schlusskurs vom Vortag:
$3.33
Offen:
$3.21
24-Stunden-Volumen:
24,486
Relative Volume:
0.51
Marktkapitalisierung:
$134.04M
Einnahmen:
$11.51M
Nettoeinkommen (Verlust:
$-101.84M
KGV:
-1.1492
EPS:
-2.6714
Netto-Cashflow:
$-82.98M
1W Leistung:
+3.37%
1M Leistung:
+7.34%
6M Leistung:
-47.88%
1J Leistung:
-48.66%
1-Tages-Spanne:
$3.00
$3.23
1-Wochen-Bereich:
$3.00
$3.35
52-Wochen-Spanne:
$2.76
$8.64
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
3.07 | 145.40M | 11.51M | -101.84M | -82.98M | -2.6714 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Nyxoah SA reports results for the quarter ended March 31Earnings Summary - TradingView
Nyxoah Q1 Earnings Call Highlights - Yahoo Finance
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Nyxoah Q1 2026 sees strong U.S. growth, stock dips - Investing.com
Nyxoah Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Nyxoah Calls June 10 Shareholder Meetings and Files Q1 2026 Results - TipRanks
Nyxoah (Nasdaq: NYXH) posts Q1 2026 surge in revenue but flags funding risk - Stock Titan
Nyxoah : Q1 Report 2026 - marketscreener.com
Sleep apnea device maker Nyxoah posts €6.4m sales, €20.5m loss - Stock Titan
Stifel cuts Nyxoah stock rating on reimbursement challenges - Investing.com
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Nyxoah to let registered holders follow June 10 meetings by video - Stock Titan
Invitation to attend the annual and the extraordinary - GlobeNewswire
Nyxoah SA (NYXH) may report negative earnings: Know the trend ahead of next week's release - MSN
Earnings Preview: Nyxoah SA to Report Financial Results on May 12 - 富途牛牛
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
How The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed Targets - Yahoo Finance
Nyxoah (NYXH) Earnings Date and Reports 2026 - MarketBeat
Nyxoah : to Participate in the Bank of America 2026 Healthcare Conference - marketscreener.com
Latest NYXH NewsNyxoah Announces Pricing of Nasdaq Public O... - Stock Titan
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference - The Manila Times
Nyxoah (NYXH) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Nyxoah (NYXH) 2024 Cantor Fitzgerald Global Healthcare Conference Summary - Quartr
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 - Sahm
Nyxoah sets May 12 for Q1 results and 4:30 p.m. ET webcast - Stock Titan
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy - MSN
Nyxoah (NYXH) Stock Forecast & Price Target - Investing.com
Nyxoah SA (NYXH) Stock: Directional Bias Review | Q4 2025: EPS Misses ViewsSubscription Growth - Xã Châu Thành
NYXH (Nyxoah SA Ordinary Shares) posts 121 percent year over year revenue growth, shares rise 3.21 percent.EBITDA Margin - Cổng thông tin điện tử tỉnh Tây Ninh
Nyxoah SA (NYXH) Stock Position Trade (Grinds Higher) 2026-04-20Retail Picks - newser.com
Baird lowers its price target on Nyxoah SA (NYXH) to $4.62 from $5.87 - MSN
Nyxoah SA (NYXH) Stock Analysis: Exploring a 208% Potential Upside in the Medical Tech Sector - DirectorsTalk Interviews
Nyxoah's Stock Rebounds 12% in Session After a 52% Annual Decline - Idéal Investisseur
Aug PreEarnings: Is Nyxoah SA forming bullish engulfing patterns2026 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn
How do market conditions affect Nyxoah SA (NYXH) Stock | Price at $2.87, Up 0.35%Community Volume Signals - Xã Thanh Hà
Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $4.62 - 富途牛牛
Today's Analyst Ratings for Nyxoah (NYXH): Stock Price Target Lo - GuruFocus
Stifel cuts Nyxoah stock price target to $8 on valuation review - Investing.com Canada
Stifel cuts Nyxoah stock price target to $8 on valuation review By Investing.com - Investing.com South Africa
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $8 - 富途牛牛
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 - NTB Kommunikasjon
Market Overview: Can Nyxoah SA expand into new marketsPortfolio Gains Report & Consistent Profit Alerts - baoquankhu1.vn
Growth Review: Is now the right time to enter Nyxoah SA2026 Levels & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Breakouts: Will Nyxoah SA benefit from AI trendsWeekly Gains Report & AI Based Buy and Sell Signals - baoquankhu1.vn
NYXH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87 - Insider Monkey
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
3.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):